Fact CheckerSign in

NCT06795763Enrolling by invitation

Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures

Chronic Total Occlusion (CTO) Crossing, Re-entry and Imaging With the Acolyte™ Catheter System in Subjects Undergoing Percutaneous Coronary Interventional (PCI) Procedures

Source: ClinicalTrials.gov · Last updated 19 May 2026

Brief summary (registry, in English)

This is a study to evaluate the safety and effectiveness of the Acolyte Catheter System used in CTO-PCI procedures. The system will be used for the placement and positioning of guidewires and catheters in the coronary vasculature for the treatment of patients with coronary chronic total occlusions with persistent symptoms following medical therapy.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
115 (estimated)
First submitted
16 Jan 2025
Start date
6 Aug 2025
Primary completion date
1 Sept 2026
Lead sponsor
Elumn8 Medical
NCT number
NCT06795763

What you commit to

  • Study type: Interventional
  • Planned participants: 115
  • From 6 Aug 2025 to the primary completion date, 1 Sept 2026
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subject has evidence of acute myocardial infarction (MI) within 72 hours prior to the intended treatment
  • Subject has had previous coronary interventional procedure of any kind within 30 days prior to the investigational procedure
  • History of stroke or transient ischemic attack within 6 months prior to procedure
  • Active peptic ulcer or upper gastrointestinal bleeding within 6 months prior to procedure
  • Subject participating in an investigational drug or device study that has not completed the primary endpoint or that clinically interferes with this study's endpoints; or requires coronary angiography, intravascular ultrasound, or other coronary artery imaging procedures

Other illness

  • Subject has history of allergy to iodinated contrast that cannot be managed medically
  • History of bleeding diathesis or coagulopathy or refusal of blood transfusions
  • Other pathology such as cancer, known mental illness, etc., or other condition which might, in the opinion of the Investigator, put the patient at risk or confound the results of the study

Other

  • Atherectomy procedure is planned for the target lesion

Who the study is looking for

  • Subject is \> 18 years of age at the time of consent
  • Subject is on medical therapy and continues to experience clinical symptoms considered suggestive of ischemic heart disease (e.g., chest pain or discomfort, heart failure) or has evidence of myocardial ischemia (e.g., abnormal functional study) attributed to the CTO target vessel and is scheduled for clinically indicated percutaneous revascularization
  • Female subjects of reproductive potential must have a negative pregnancy test per standard of care for PCI
  • Subject is willing and able to provided written informed consent
  • Subject is willing to and able to comply with the study protocol requirements including all follow up visits post-procedure

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
PharmaTex Research
Coordinator of this site? Confirm its status
AmarilloUnited StatesUnknown status
Piedmont Heart Institute
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
Emory University Hospital
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
Minneapolis Heart Institute Foundation
Coordinator of this site? Confirm its status
MinneapolisUnited StatesUnknown status
St. Francis Hospital
Coordinator of this site? Confirm its status
RoslynUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.